Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Trislan-Noguero A., Borras E., Molero-Luis M., Wassenberg T., Peters T., Verbeek M. M. , ...More

MOVEMENT DISORDERS, vol.36, pp.690-703, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36
  • Publication Date: 2021
  • Doi Number: 10.1002/mds.28362
  • Journal Indexes: Science Citation Index Expanded, Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.690-703


Background Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia.